nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoprofen—PTGS2—amyotrophic lateral sclerosis	0.818	1	CbGaD
Fenoprofen—Personality change—Riluzole—amyotrophic lateral sclerosis	0.0253	0.147	CcSEcCtD
Fenoprofen—Supraventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00741	0.0432	CcSEcCtD
Fenoprofen—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.00557	0.0324	CcSEcCtD
Fenoprofen—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00456	0.0265	CcSEcCtD
Fenoprofen—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00432	0.0252	CcSEcCtD
Fenoprofen—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00413	0.0241	CcSEcCtD
Fenoprofen—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00394	0.0229	CcSEcCtD
Fenoprofen—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00374	0.0218	CcSEcCtD
Fenoprofen—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00372	0.0217	CcSEcCtD
Fenoprofen—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00366	0.0213	CcSEcCtD
Fenoprofen—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00353	0.0205	CcSEcCtD
Fenoprofen—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00353	0.0205	CcSEcCtD
Fenoprofen—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00312	0.0182	CcSEcCtD
Fenoprofen—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00299	0.0174	CcSEcCtD
Fenoprofen—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00289	0.0168	CcSEcCtD
Fenoprofen—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00285	0.0166	CcSEcCtD
Fenoprofen—Depression—Riluzole—amyotrophic lateral sclerosis	0.00271	0.0158	CcSEcCtD
Fenoprofen—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00265	0.0154	CcSEcCtD
Fenoprofen—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00259	0.0151	CcSEcCtD
Fenoprofen—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00254	0.0148	CcSEcCtD
Fenoprofen—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00245	0.0143	CcSEcCtD
Fenoprofen—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00244	0.0142	CcSEcCtD
Fenoprofen—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.0024	0.014	CcSEcCtD
Fenoprofen—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00231	0.0134	CcSEcCtD
Fenoprofen—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00215	0.0125	CcSEcCtD
Fenoprofen—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00209	0.0122	CcSEcCtD
Fenoprofen—Tension—Riluzole—amyotrophic lateral sclerosis	0.00208	0.0121	CcSEcCtD
Fenoprofen—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00208	0.0121	CcSEcCtD
Fenoprofen—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00206	0.012	CcSEcCtD
Fenoprofen—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00199	0.0116	CcSEcCtD
Fenoprofen—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00197	0.0115	CcSEcCtD
Fenoprofen—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00194	0.0113	CcSEcCtD
Fenoprofen—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00191	0.0111	CcSEcCtD
Fenoprofen—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00188	0.0109	CcSEcCtD
Fenoprofen—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00184	0.0107	CcSEcCtD
Fenoprofen—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00179	0.0104	CcSEcCtD
Fenoprofen—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00177	0.0103	CcSEcCtD
Fenoprofen—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00175	0.0102	CcSEcCtD
Fenoprofen—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00173	0.0101	CcSEcCtD
Fenoprofen—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.0017	0.00988	CcSEcCtD
Fenoprofen—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00985	CcSEcCtD
Fenoprofen—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00167	0.00975	CcSEcCtD
Fenoprofen—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00165	0.00962	CcSEcCtD
Fenoprofen—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00912	CcSEcCtD
Fenoprofen—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00899	CcSEcCtD
Fenoprofen—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00897	CcSEcCtD
Fenoprofen—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00888	CcSEcCtD
Fenoprofen—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00877	CcSEcCtD
Fenoprofen—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00871	CcSEcCtD
Fenoprofen—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00149	0.0087	CcSEcCtD
Fenoprofen—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00863	CcSEcCtD
Fenoprofen—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00831	CcSEcCtD
Fenoprofen—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00825	CcSEcCtD
Fenoprofen—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00801	CcSEcCtD
Fenoprofen—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00798	CcSEcCtD
Fenoprofen—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00798	CcSEcCtD
Fenoprofen—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00743	CcSEcCtD
Fenoprofen—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00724	CcSEcCtD
Fenoprofen—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00714	CcSEcCtD
Fenoprofen—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00119	0.0069	CcSEcCtD
Fenoprofen—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00667	CcSEcCtD
Fenoprofen—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00641	CcSEcCtD
Fenoprofen—Rash—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00636	CcSEcCtD
Fenoprofen—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00636	CcSEcCtD
Fenoprofen—Headache—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00632	CcSEcCtD
Fenoprofen—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00599	CcSEcCtD
Fenoprofen—Carprofen—PTGS2—amyotrophic lateral sclerosis	0.000868	0.141	CrCbGaD
Fenoprofen—Tiaprofenic acid—PTGS2—amyotrophic lateral sclerosis	0.000708	0.115	CrCbGaD
Fenoprofen—Nepafenac—PTGS2—amyotrophic lateral sclerosis	0.000673	0.109	CrCbGaD
Fenoprofen—Fenbufen—PTGS2—amyotrophic lateral sclerosis	0.000644	0.104	CrCbGaD
Fenoprofen—Salsalate—PTGS2—amyotrophic lateral sclerosis	0.000559	0.0907	CrCbGaD
Fenoprofen—Suprofen—PTGS2—amyotrophic lateral sclerosis	0.000536	0.0869	CrCbGaD
Fenoprofen—Bumetanide—PTGS2—amyotrophic lateral sclerosis	0.000488	0.0791	CrCbGaD
Fenoprofen—Mefenamic acid—PTGS2—amyotrophic lateral sclerosis	0.000429	0.0695	CrCbGaD
Fenoprofen—Naproxen—PTGS2—amyotrophic lateral sclerosis	0.000421	0.0682	CrCbGaD
Fenoprofen—Flurbiprofen—PTGS2—amyotrophic lateral sclerosis	0.000302	0.0489	CrCbGaD
Fenoprofen—Ketoprofen—PTGS2—amyotrophic lateral sclerosis	0.000273	0.0442	CrCbGaD
Fenoprofen—Ibuprofen—PTGS2—amyotrophic lateral sclerosis	0.000269	0.0435	CrCbGaD
Fenoprofen—PTGS2—Spinal Cord Injury—PTPRZ1—amyotrophic lateral sclerosis	0.000159	0.0362	CbGpPWpGaD
Fenoprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—RAB5A—amyotrophic lateral sclerosis	0.000156	0.0354	CbGpPWpGaD
Fenoprofen—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—TPK1—amyotrophic lateral sclerosis	0.000154	0.035	CbGpPWpGaD
Fenoprofen—PTGS1—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	9.71e-05	0.0221	CbGpPWpGaD
Fenoprofen—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—amyotrophic lateral sclerosis	9.66e-05	0.022	CbGpPWpGaD
Fenoprofen—PTGS1—Prostaglandin Synthesis and Regulation—PLA2G4A—amyotrophic lateral sclerosis	9.32e-05	0.0212	CbGpPWpGaD
Fenoprofen—ALB—HDL-mediated lipid transport—APOE—amyotrophic lateral sclerosis	8.57e-05	0.0195	CbGpPWpGaD
Fenoprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—ATF1—amyotrophic lateral sclerosis	8.53e-05	0.0194	CbGpPWpGaD
Fenoprofen—PTGS2—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	7.71e-05	0.0175	CbGpPWpGaD
Fenoprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—amyotrophic lateral sclerosis	7.6e-05	0.0173	CbGpPWpGaD
Fenoprofen—PTGS1—Overview of nanoparticle effects—PTGS2—amyotrophic lateral sclerosis	7.57e-05	0.0172	CbGpPWpGaD
Fenoprofen—PTGS2—Prostaglandin Synthesis and Regulation—PLA2G4A—amyotrophic lateral sclerosis	7.4e-05	0.0168	CbGpPWpGaD
Fenoprofen—ALB—Platelet degranulation—TUBA4A—amyotrophic lateral sclerosis	6.99e-05	0.0159	CbGpPWpGaD
Fenoprofen—ALB—Response to elevated platelet cytosolic Ca2+—TUBA4A—amyotrophic lateral sclerosis	6.66e-05	0.0152	CbGpPWpGaD
Fenoprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—PLA2G4A—amyotrophic lateral sclerosis	6.54e-05	0.0149	CbGpPWpGaD
Fenoprofen—ALB—Platelet degranulation—PFN1—amyotrophic lateral sclerosis	6.3e-05	0.0143	CbGpPWpGaD
Fenoprofen—PTGS1—Eicosanoid Synthesis—PTGS2—amyotrophic lateral sclerosis	6.28e-05	0.0143	CbGpPWpGaD
Fenoprofen—ALB—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	6.24e-05	0.0142	CbGpPWpGaD
Fenoprofen—PTGS2—Spinal Cord Injury—RTN4—amyotrophic lateral sclerosis	6.21e-05	0.0141	CbGpPWpGaD
Fenoprofen—PTGS1—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.19e-05	0.0141	CbGpPWpGaD
Fenoprofen—ALB—Response to elevated platelet cytosolic Ca2+—PFN1—amyotrophic lateral sclerosis	6e-05	0.0137	CbGpPWpGaD
Fenoprofen—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—amyotrophic lateral sclerosis	5.43e-05	0.0124	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	5.29e-05	0.012	CbGpPWpGaD
Fenoprofen—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—amyotrophic lateral sclerosis	5.25e-05	0.012	CbGpPWpGaD
Fenoprofen—PTGS2—Spinal Cord Injury—GFAP—amyotrophic lateral sclerosis	5.06e-05	0.0115	CbGpPWpGaD
Fenoprofen—PTGS2—Spinal Cord Injury—AQP4—amyotrophic lateral sclerosis	5.01e-05	0.0114	CbGpPWpGaD
Fenoprofen—ALB—Lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	4.92e-05	0.0112	CbGpPWpGaD
Fenoprofen—PTGS2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.92e-05	0.0112	CbGpPWpGaD
Fenoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—amyotrophic lateral sclerosis	4.92e-05	0.0112	CbGpPWpGaD
Fenoprofen—PTGS2—S1P1 pathway—VEGFA—amyotrophic lateral sclerosis	4.73e-05	0.0108	CbGpPWpGaD
Fenoprofen—PTGS1—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	4.39e-05	0.00999	CbGpPWpGaD
Fenoprofen—ALB—Vitamin B12 Metabolism—SOD1—amyotrophic lateral sclerosis	4.36e-05	0.00993	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	4.31e-05	0.00982	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	4.31e-05	0.00981	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	3.95e-05	0.00898	CbGpPWpGaD
Fenoprofen—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—amyotrophic lateral sclerosis	3.83e-05	0.00873	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	3.67e-05	0.00835	CbGpPWpGaD
Fenoprofen—ALB—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	3.55e-05	0.00808	CbGpPWpGaD
Fenoprofen—PTGS1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	3.49e-05	0.00794	CbGpPWpGaD
Fenoprofen—PTGS2—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	3.49e-05	0.00793	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.45e-05	0.00785	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	3.43e-05	0.0078	CbGpPWpGaD
Fenoprofen—ALB—Lipid and lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	3.27e-05	0.00745	CbGpPWpGaD
Fenoprofen—ALB—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	3.22e-05	0.00733	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	3.13e-05	0.00713	CbGpPWpGaD
Fenoprofen—ALB—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	3.1e-05	0.00706	CbGpPWpGaD
Fenoprofen—ALB—Platelet degranulation—SOD1—amyotrophic lateral sclerosis	3.04e-05	0.00693	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	2.96e-05	0.00674	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	2.91e-05	0.00663	CbGpPWpGaD
Fenoprofen—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—amyotrophic lateral sclerosis	2.9e-05	0.0066	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	2.87e-05	0.00654	CbGpPWpGaD
Fenoprofen—ALB—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	2.82e-05	0.00642	CbGpPWpGaD
Fenoprofen—ALB—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	2.79e-05	0.00636	CbGpPWpGaD
Fenoprofen—ALB—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	2.77e-05	0.00631	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	2.74e-05	0.00623	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	2.71e-05	0.00616	CbGpPWpGaD
Fenoprofen—PTGS2—Spinal Cord Injury—BDNF—amyotrophic lateral sclerosis	2.59e-05	0.0059	CbGpPWpGaD
Fenoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—amyotrophic lateral sclerosis	2.57e-05	0.00585	CbGpPWpGaD
Fenoprofen—ALB—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	2.53e-05	0.00577	CbGpPWpGaD
Fenoprofen—ALB—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	2.53e-05	0.00576	CbGpPWpGaD
Fenoprofen—PTGS1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.51e-05	0.00571	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.36e-05	0.00538	CbGpPWpGaD
Fenoprofen—ALB—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	2.36e-05	0.00536	CbGpPWpGaD
Fenoprofen—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	2.33e-05	0.00531	CbGpPWpGaD
Fenoprofen—ALB—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	2.31e-05	0.00525	CbGpPWpGaD
Fenoprofen—PTGS1—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	2.22e-05	0.00505	CbGpPWpGaD
Fenoprofen—ALB—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	2.22e-05	0.00504	CbGpPWpGaD
Fenoprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—amyotrophic lateral sclerosis	2.19e-05	0.00499	CbGpPWpGaD
Fenoprofen—ALB—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	2.15e-05	0.0049	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	2.09e-05	0.00476	CbGpPWpGaD
Fenoprofen—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	2e-05	0.00454	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—TPK1—amyotrophic lateral sclerosis	1.92e-05	0.00437	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—VAPB—amyotrophic lateral sclerosis	1.92e-05	0.00437	CbGpPWpGaD
Fenoprofen—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	1.92e-05	0.00437	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	1.88e-05	0.00427	CbGpPWpGaD
Fenoprofen—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	1.86e-05	0.00422	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—TPK1—amyotrophic lateral sclerosis	1.82e-05	0.00415	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.79e-05	0.00408	CbGpPWpGaD
Fenoprofen—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	1.77e-05	0.00402	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	1.76e-05	0.00401	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—VAPA—amyotrophic lateral sclerosis	1.76e-05	0.004	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	1.68e-05	0.00383	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.63e-05	0.00372	CbGpPWpGaD
Fenoprofen—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	1.6e-05	0.00364	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.54e-05	0.0035	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—TPK1—amyotrophic lateral sclerosis	1.53e-05	0.00347	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—VAPB—amyotrophic lateral sclerosis	1.53e-05	0.00347	CbGpPWpGaD
Fenoprofen—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	1.52e-05	0.00346	CbGpPWpGaD
Fenoprofen—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	1.49e-05	0.00338	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—VTA1—amyotrophic lateral sclerosis	1.46e-05	0.00331	CbGpPWpGaD
Fenoprofen—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	1.44e-05	0.00328	CbGpPWpGaD
Fenoprofen—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	1.43e-05	0.00325	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.42e-05	0.00324	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—VAPA—amyotrophic lateral sclerosis	1.4e-05	0.00318	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—DAO—amyotrophic lateral sclerosis	1.39e-05	0.00316	CbGpPWpGaD
Fenoprofen—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	1.35e-05	0.00307	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.3e-05	0.00295	CbGpPWpGaD
Fenoprofen—PTGS2—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	1.29e-05	0.00295	CbGpPWpGaD
Fenoprofen—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	1.29e-05	0.00293	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	1.23e-05	0.00281	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	1.23e-05	0.00281	CbGpPWpGaD
Fenoprofen—PTGS2—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	1.22e-05	0.00278	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—FIG4—amyotrophic lateral sclerosis	1.22e-05	0.00278	CbGpPWpGaD
Fenoprofen—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	1.21e-05	0.00276	CbGpPWpGaD
Fenoprofen—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	1.21e-05	0.00276	CbGpPWpGaD
Fenoprofen—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	1.16e-05	0.00263	CbGpPWpGaD
Fenoprofen—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.15e-05	0.00262	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	1.14e-05	0.0026	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	1.13e-05	0.00257	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—CHMP2B—amyotrophic lateral sclerosis	1.1e-05	0.00251	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—DAO—amyotrophic lateral sclerosis	1.1e-05	0.00251	CbGpPWpGaD
Fenoprofen—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	1.09e-05	0.00249	CbGpPWpGaD
Fenoprofen—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	1.09e-05	0.00249	CbGpPWpGaD
Fenoprofen—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	1.07e-05	0.00243	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.05e-05	0.0024	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.05e-05	0.00239	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—PLB1—amyotrophic lateral sclerosis	9.98e-06	0.00227	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	9.87e-06	0.00225	CbGpPWpGaD
Fenoprofen—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	9.75e-06	0.00222	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—GSR—amyotrophic lateral sclerosis	9.72e-06	0.00221	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	8.92e-06	0.00203	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—VCP—amyotrophic lateral sclerosis	8.9e-06	0.00202	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	8.85e-06	0.00201	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	8.8e-06	0.002	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—PLB1—amyotrophic lateral sclerosis	8.36e-06	0.0019	CbGpPWpGaD
Fenoprofen—PTGS2—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	8.3e-06	0.00189	CbGpPWpGaD
Fenoprofen—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	8.23e-06	0.00187	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—CHAT—amyotrophic lateral sclerosis	7.98e-06	0.00182	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—GSR—amyotrophic lateral sclerosis	7.71e-06	0.00176	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	7.47e-06	0.0017	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.28e-06	0.00166	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	7.02e-06	0.0016	CbGpPWpGaD
Fenoprofen—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	6.96e-06	0.00158	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	6.76e-06	0.00154	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—CST3—amyotrophic lateral sclerosis	6.38e-06	0.00145	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—CHAT—amyotrophic lateral sclerosis	6.33e-06	0.00144	CbGpPWpGaD
Fenoprofen—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	6.24e-06	0.00142	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	6.24e-06	0.00142	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	5.78e-06	0.00132	CbGpPWpGaD
Fenoprofen—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.68e-06	0.00129	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	5.64e-06	0.00128	CbGpPWpGaD
Fenoprofen—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	5.38e-06	0.00122	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	5.12e-06	0.00117	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.99e-06	0.00114	CbGpPWpGaD
Fenoprofen—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.68e-06	0.00106	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—CASP9—amyotrophic lateral sclerosis	4.64e-06	0.00106	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.29e-06	0.000976	CbGpPWpGaD
Fenoprofen—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	4.24e-06	0.000966	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—ERBB4—amyotrophic lateral sclerosis	3.97e-06	0.000904	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.94e-06	0.000897	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.4e-06	0.000775	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—APOE—amyotrophic lateral sclerosis	3.24e-06	0.000738	CbGpPWpGaD
Fenoprofen—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.2e-06	0.000729	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.13e-06	0.000712	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—APOE—amyotrophic lateral sclerosis	3.07e-06	0.000699	CbGpPWpGaD
Fenoprofen—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.77e-06	0.000631	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.75e-06	0.000627	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—APOE—amyotrophic lateral sclerosis	2.57e-06	0.000586	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.53e-06	0.000576	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.22e-06	0.000506	CbGpPWpGaD
Fenoprofen—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	2.09e-06	0.000477	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	2.08e-06	0.000474	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.43e-06	0.000325	CbGpPWpGaD
